Abpro Bio Co., Ltd. (KOSDAQ:195990)

Silk Road Medical Revenue

Abpro Bio had revenue of 8.87B KRW in the quarter ending March 31, 2025, with 45.31% growth. This brings the company's revenue in the last twelve months to 34.43B, up 47.60% year-over-year. In the year 2024, Abpro Bio had annual revenue of 31.66B with 24.78% growth.

• Revenue (ttm): 34.43B
• Revenue Growth: +47.60%
• P/S Ratio: 1.93
• Revenue / Employee: 765.10M
• Employees: 45
• Market Cap: 66.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	31.66B	6.29B	24.78%
Dec 31, 2023	25.38B	3.26B	14.76%
Dec 31, 2022	22.11B	-10.80B	-32.82%
Dec 31, 2021	32.91B	-2.88B	-8.05%
Dec 31, 2020	35.80B	3.87B	12.11%